Skip to main content
. 2021 Apr;10(4):1907–1915. doi: 10.21037/tcr-21-589

Table 3. Baseline tumor characteristics and treatment between patients with and without tumor progression.

Characteristics Progression (n=165) Non-progression (n=122) t/X2 value P value
Location 1.411 0.703
   Supracerebral lobe (n=219) 127 (77.0) 92 (75.4)
   Supracerebral midline (n=34) 18 (10.9) 16 (13.1)
   Cerebellum (n=29) 16 (9.7) 13 (10.7)
   Brain stem (n=5) 4 (2.4) 1 (0.8)
Diameter (mm) 32.7±9.3 29.4±8.8 3.040 0.003
Classification 1.029 0.599
   Oligodendroglioma 27 (16.4) 20 (16.4)
   Astrocytoma 118 (71.5) 87 (71.3)
   Oligoastrocytoma 20 (12.1) 15 (112.3)
Operation 6.525 0.011
   Partial resection 106 (64.2) 60 (49.2)
   Total/enlarged resection 59 (35.8) 62 (50.8)
Radiotherapy 0.182 0.670
   Yes 84 (50.9) 59 (48.4)
   No 81 (49.1) 63 (51.6)
Chemotherapy 0.038 0.846
   Yes 79 (47.9) 57 (46.7)
   No 86 (52.1) 65 (53.3)